Funding opportunities
308 live opportunities from Grants.gov, NIH, NSF, and more.
Defense & Security× remove
- Response and defense mechanisms of extraintestinal Escherichia coli to reactive oxygen and chlorine speciesNational Institute of Allergy and Infectious DiseasesPAR-25-134 closes 5/31/2029up to $555,000activenih
- Coordinating Austere Nodes through Virtualization and Analysis of Streams (CANVAS)Air Force -- Research LabFA875024S7003 closes 5/22/2029postedgrants.gov
- Pancreatic beta-cell glucose toxicity and mRNA translationNational Institute of Diabetes and Digestive and Kidney DiseasesPAR-21-271 closes 4/30/2029up to $248,975activenih
- ARMY APPLICATIONS LAB BROAD AGENCY ANNOUNCEMENT FOR DISRUPTIVE APPLICATIONSDept of the Army -- Materiel CommandW911NF-24-S-0008 closes 4/4/2029postedgrants.gov
- FOUNDATIONS OF TRUSTED SYSTEMSAir Force -- Research LabFA875025S7001 closes 12/5/2028postedgrants.gov
- Defense Security Cooperation University - Research GrantsWashington Headquarters ServicesHQ003423NFOEASD17 closes 8/7/2028postedgrants.gov
- BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of DefenseDept. of the Army -- USAMRAAHT9425-23-S-SOC1 closes 7/31/2028postedgrants.gov
- Mechanisms of AP-Site Identification and Processing at Replication Forks by APE1National Institute of Environmental Health SciencesPA-25-422 closes 6/6/2028up to $42,599activenih
- The role of constitutive interferon-kappa production in antiviral defense in human skinNational Institute of Allergy and Infectious DiseasesPA-23-271 closes 6/3/2028up to $35,446activenih
- Improved Aminopyridine Analogs for Symptomatic Treatment of BotulismNational Institute of Allergy and Infectious DiseasesRFA-AI-24-080 closes 5/31/2028up to $480,448activenih
- Proteasome Inhibitors as a Novel Drug-class for Treatment of GiardiasisNational Institute of Allergy and Infectious DiseasesPA-23-271 closes 5/31/2028up to $43,626activenih
- Biobehavioral Signatures of Repetitive Head Impacts at the Intersection of Aging and Alzheimer's DiseaseNational Institute on AgingPAR-25-332 closes 5/31/2028up to $439,739activenih
- Mechanism of Transposon Silencing in the BrainNational Institute of Neurological Disorders and StrokePA-25-150 closes 5/31/2028up to $415,250activenih
- Role of the DEAH-Box RNA helicase DHX29 during Class Switch Recombination in B-cellsNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $195,625activenih
- Growth in Medicare Advantage Enrollment and its Implications for Cancer Care QualityNational Cancer InstitutePAR-23-286 closes 5/31/2028up to $83,811activenih
- Pathways and Mechanisms of Drug Resistance Evolution in HIVNational Institute of Allergy and Infectious DiseasesPA-24-194 closes 5/31/2028up to $161,868activenih
- Investigation of a novel mycovirus and its impacts on the biology and pathogenesis of Cryptococcus neoformansNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $242,250activenih
- Beyond blocking virus entry: Role of SERINC5 as a shield of genomic integrityNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $407,091activenih
- PRIME-HIV: Personalized, Real-time Interactive Medical Education in HIV.National Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $426,823activenih
- Milk regulates interferon-stimulated immunity in the neonatal gut epitheliumNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $234,000activenih
- Elucidating the functional limitations of cDC1 in Glioblastoma to inform immunotherapeutic strategies.National Cancer InstitutePA-23-272 closes 5/31/2028up to $39,692activenih
- Manipulating PIWI-interacting RNA to generate sterile ticksNational Institute of Allergy and Infectious DiseasesPA-25-302 closes 5/31/2028up to $150,000activenih
- I3-BC: Image-Based Infiltrating Immune Cell Detection and Outcomes in Breast Cancer Clinical TrialsNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $394,695activenih
- Factors Associated with Comprehensive TBI Evaluation CompletionVeterans AffairsRD-01-PILT closes 5/31/2028activenih
- Cellular Glue Therapeutics to Enhance Innate Immune Responses Against Fungal PathogensNational Institute of Allergy and Infectious DiseasesRFA-AI-24-065 closes 5/31/2028up to $172,028activenih